{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:58:19Z","timestamp":1793350699259,"version":"4.5.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-noi260008-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Differentiating multiple sclerosis (MS) from myelin oligodendrocyte glycoprotein antibody\u2013associated disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD), especially in seronegative cases, remains challenging due to overlapping clinical and imaging features. High-level Epstein-Barr virus (EBV)\u2013derived Epstein-Barr nuclear antigen 1 (EBNA-1) peptide antibody titers may be an MS-specific biomarker that could the improve differential diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether longitudinal EBNA-1 peptide antibodies can distinguish MS from MOGAD and NMOSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a retrospective, multicenter, longitudinal, case-control study with patients from Austria, Germany, and the US. This study assessed samples from 2 independent retrospective cohorts. A test cohort and a validation cohort assessed longitudinal plasma samples from patients with MS, MOGAD, or NMOSD. Patients were recruited between 2001 and 2023 and followed up for 2 years. A combined analysis of both cohorts was conducted in January 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Plasma EBNA-1 peptide immunoglobulin G (IgG) titers measured by enzyme-linked immunosorbent assay after diagnosis and in 3 follow-up samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Diagnostic utility of persistent EBNA-1 peptide antibody levels across 4 time points in patients with MS compared with patients with MOGAD and NMOSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included the plasma samples of 2091 patients (mean [SD] age, 31.0 [16.9] years; 1137 female [54.4%]) with neuroinflammatory disease and 1976 healthy controls (mean [SD] age, 39.8 [16.2] years; 1120 male [56.7%]) recruited between 2001 and 2023. The test cohort (310 patients; 54.8% female) included 184 patients with MS, 65 with MOGAD, and 61 with NMOSD (including 12 who were seronegative for aquaporin 4 [AQP4] IgG). The validation cohort (183 patients; 126 female [68.8%]) included 142 patients with MS, 24 with MOGAD, and 17 with NMOSD. In the test cohort, 177 patients with MS (96.2%) had high-level titers in 2 or more of 4 follow-up samples compared with 5 patients (7.7%) with MOGAD (odds ratio [OR], 303.4; 95% CI, 94.4-908.6) and 11 patients (18.0%) with NMOSD (OR, 114.9; 95% CI, 43.0-280.0). Among patients with NMOSD who were seronegative for AQP4-IgG, only 1 (11.1%) had persistent high-level EBNA-1 peptide antibody titers compared with 61 matched patients (96.7%) with MS (OR, 236.0; 95% CI, 18.6-2588.0). In the validation cohort, 135 patients (95.1%) with MS had high-level titers in 2 or more of 4 follow-up samples compared with 4 patients (16.7%) with MOGAD (OR, 96.4; 95% CI, 26.6-293.0) and 3 patients (17.6%) with NMOSD (OR, 90.0; 95% CI, 19.7-319.7).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-noi260008-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Results of this case-control study reveal that persistent high-level EBNA-1 peptide antibody titers may serve as a reliable biomarker for differentiating MS from MOGAD, and NMOSD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaneurol.2026.0240","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:00:33Z","timestamp":1773068433000},"page":"461","source":"Crossref","is-referenced-by-count":8,"title":["Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases"],"prefix":"10.1001","volume":"83","author":[{"given":"Hannes","family":"Vietzen","sequence":"first","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"K\u00fchner","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Berger","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Reinecke","sequence":"additional","affiliation":[{"name":"Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria"},{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Rost\u00e1sy","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrieke","family":"Saucke","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Kauth","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Koukou","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sommer","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"},{"name":"Chair of Biochemistry and Molecular Medicine, Faculty of Health, Centre for Biomedical Education and Research, Witten\/Herdecke University, Witten, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Wendel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Children\u2019s Hospital Datteln, Witten\/Herdecke University, Datteln, Germany"},{"name":"Department of Pediatric Neurology, Olgahospital\/Klinikum Stuttgart, Teaching Hospital Medical University Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Graninger","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy V.","family":"Camp","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle L.","family":"Waubant","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Charles","family":"Casper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Benson","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanuja","family":"Chitnis","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Aaen","sequence":"additional","affiliation":[{"name":"Loma Linda University, Loma Linda, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soe","family":"Mar","sequence":"additional","affiliation":[{"name":"Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[{"name":"Jacobs School of Medicine and Biomedical Sciences, University of Buffalo Jacobs School of Medicine, Buffalo, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Lotze","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Child Neurology, Baylor College of Medicine, Texas Children\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren B.","family":"Krupp","sequence":"additional","affiliation":[{"name":"NYU Grossman School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lassmann","sequence":"additional","affiliation":[{"name":"Center for Brain Research, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Weidner","sequence":"additional","affiliation":[{"name":"Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pistorius","sequence":"additional","affiliation":[{"name":"Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Jungbauer","sequence":"additional","affiliation":[{"name":"Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria"},{"name":"Department for Transfusion Medicine, University Hospital, Paracelsus Medical University, Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Ponleitner","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Reindl","sequence":"additional","affiliation":[{"name":"Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kornek","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Breu","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Bsteh","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[{"name":"Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Berger","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Puchhammer-St\u00f6ckl","sequence":"additional","affiliation":[{"name":"Center for Virology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Rommer","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria"},{"name":"Department of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"noi260008r1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum.","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"noi260008r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103693","article-title":"MOGAD: a comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally.","volume":"24","author":"Trewin","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"3","key":"noi260008r3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria.","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi260008r4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein-Barr virus and multiple sclerosis.","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"7900","key":"noi260008r5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"20","key":"noi260008r6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg3032","article-title":"Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis.","volume":"9","author":"Thomas","year":"2023","journal-title":"Sci Adv"},{"issue":"21","key":"noi260008r7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184481","article-title":"Accumulation of Epstein-Barr virus\u2013induced cross-reactive immune responses is associated with multiple sclerosis.","volume":"134","author":"Vietzen","year":"2024","journal-title":"J Clin Invest"},{"issue":"34","key":"noi260008r8","doi-asserted-by":"publisher","first-page":"16955","DOI":"10.1073\/pnas.1902623116","article-title":"Molecular mimicry between anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.","volume":"116","author":"Tengvall","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"noi260008r9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1084\/jem.20072397","article-title":"EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.","volume":"205","author":"L\u00fcnemann","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"noi260008r10","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/s41467-025-61751-9","article-title":"Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titers.","volume":"16","author":"Vietzen","year":"2025","journal-title":"Nat Commun"},{"issue":"5","key":"noi260008r11","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/ene.14705","article-title":"Quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: the VIAADISC score.","volume":"28","author":"Bsteh","year":"2021","journal-title":"Eur J Neurol"},{"issue":"6","key":"noi260008r12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209752","article-title":"Association of disease-modifying treatment with outcome in patients with relapsing multiple sclerosis and isolated MRI activity.","volume":"103","author":"Bsteh","year":"2024","journal-title":"Neurology"},{"issue":"10","key":"noi260008r13","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1177\/13524585221081090","article-title":"Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome.","volume":"28","author":"Wendel","year":"2022","journal-title":"Mult Scler"},{"key":"noi260008r14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejpn.2020.04.002","article-title":"High association of MOG-IgG antibodies in children with bilateral optic neuritis.","volume":"27","author":"Wendel","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"noi260008r16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"noi260008r17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.msard.2012.06.002","article-title":"Treatment of neuromyelitis optica: review and recommendations.","volume":"1","author":"Kimbrough","year":"2012","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"noi260008r18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2174\/1381612827666210920151231","article-title":"Treatment options in multiple sclerosis and neuromyelitis optica spectrum disorders.","volume":"28","author":"Rommer","year":"2022","journal-title":"Curr Pharm Des"},{"issue":"1","key":"noi260008r19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-022-02187-y","article-title":"Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease.","volume":"17","author":"Rath","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"noi260008r20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","article-title":"Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.","volume":"91","author":"Abrahamyan","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi260008r21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991662","article-title":"Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: a 2-years longitudinal study.","volume":"13","author":"Dom\u00ednguez-Mozo","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"noi260008r22","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ana.26062","article-title":"Multiple sclerosis is rare in Epstein-Barr virus\u2013seronegative children with central nervous system inflammatory demyelination.","volume":"89","author":"Nourbakhsh","year":"2021","journal-title":"Ann Neurol"},{"issue":"11","key":"noi260008r23","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","article-title":"High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.","volume":"67","author":"Pohl","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"noi260008r24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","article-title":"Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.","volume":"22","author":"Aloisi","year":"2023","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi260008r25","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/ene.15015","article-title":"Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysis.","volume":"28","author":"Frahm","year":"2021","journal-title":"Eur J Neurol"},{"key":"noi260008r15","doi-asserted-by":"crossref","unstructured":"Bsteh? G, F\u00f6ttinger? F, Ponleitner? M, . The Austrian MS Database and the Austrian MS Cohort\u2014a national effort towards data harmonization and prospective data collection.? medRxiv. 2025:2025.02.17.25322422. doi:10.1101\/2025.02.17.25322422","DOI":"10.1101\/2025.02.17.25322422"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2845900\/jamaneurology_vietzen_2026_oi_260008_1778071468.75546.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:00:24Z","timestamp":1778511624000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2845900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.0240","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}